Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122001 · ClinicalTrials.gov registry record · NA

Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease

A NA study of Alzheimer Disease, Early Onset and Logopenic Progressive Aphasia, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04122001: Recruiting NA study of Alzheimer Disease, Early Onset and Logopenic Progressive Aphasia, sponsored by Johns Hopkins University.

NCT04122001 is a NA study of Alzheimer Disease, Early Onset and Logopenic Progressive Aphasia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 90 participants, below the 1,480-participant average among 11 other Alzheimer Disease, Early Onset trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122001, a NA study of Alzheimer Disease, Early Onset and Logopenic Progressive Aphasia, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Alzheimer's disease (AD) is the leading neurodegenerative disease of aging characterized by multiple cognitive impairments. Given the recent failures of disease-modifying drugs, the current focus is on preventing or mitigating synaptic damage that correlates with cognitive decline in AD patients. Transcranial Direct Current Stimulation (tDCS) is a safe, non-invasive, non-painful electrical stimulation of the brain that is shown to act as a primer at the synaptic level when administered along with behavioral therapy, mostly involving language, learning and memory. Previous studies have shown that tDCS over the left angular gyrus (AG) improves language associative learning in the elderly through changes in functional connectivity between the AG and the hippocampus. The investigators' previous clinical trial on the effects of tDCS in neurodegenerative disorders has also shown augmented effects of lexical retrieval for tDCS. In the present study the investigators will compare the effects of active vs. sham tDCS over the AG-an area that is part of the default mode network but also a language area, particularly important for semantic integration and event processing-in two predominant AD variants: probable AD with amnesic phenotype (amnesic/typical AD) and probable AD with non-amnesic (language deficit) phenotype also described as logopenic variant PPA with AD pathology (aphasic/atypical AD). The investigators aim to: (1) determine whether active high-definition tDCS (HD-tDCS) targeting the left AG combined with a Word-List Learning Intervention (WordLLI) will improve verbal learning; (2) identify the changes in functional connectivity between the stimulated area (AG) and other structurally and functionally connected areas using resting-state functional magnetic resonance imaging; (3) identify changes in the inhibitory neurotransmitter GABA at the stimulation site using magnetic resonance spectroscopy. Furthermore, the investigators need to determine the characteristics o

Primary Outcome

Each trained word-list (practiced during the intervention period) will consist of 12 semantically related words (e.g., birds). Word lists will be constructed using psycholinguistic databases. There will be 5 Trials to learn each list. The investigators will compute the raw score of items correctly recalled by summing all scores from Trial 1 to Trial 5 and transforming to percent correct (range: 0-100%) at each time point of the study. Increase in scores is considered a benefit.

Interventions

  • DEVICE Sham
  • DEVICE Active, in-person HD-tDCS or active remote tDCS
  • OTHER Word List Learning Intervention (WordLLI)

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2020-08-17
Est. Completion 2026-05-31
Phase NA
Johns Hopkins University

1,448 total trials

What NCT04122001 shows while recruiting

NCT04122001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,480-participant average among 11 other Alzheimer Disease, Early Onset trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Alzheimer Disease, Early Onset appearing as the primary indexed condition, and to 3 interventions - of which Sham is the first listed.

NCT04122001 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04122001 about?

NCT04122001 is a clinical study titled "Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease". Alzheimer's disease (AD) is the leading neurodegenerative disease of aging characterized by multiple cognitive impairments. Given the recent failures of disease-modifying drugs, the current focus is on preventing or mitigating synaptic damage that correlates with cognitive decline in AD patients. Tr...

What is the current status of trial NCT04122001?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2020-08-17. Estimated completion is 2026-05-31.

What conditions does trial NCT04122001 study?

This clinical trial studies the following conditions: Alzheimer Disease, Early Onset, Logopenic Progressive Aphasia, Atypical Alzheimer's Disease.

What interventions are being tested in trial NCT04122001?

The interventions under investigation include: Sham (DEVICE), Active, in-person HD-tDCS or active remote tDCS (DEVICE), Word List Learning Intervention (WordLLI) (OTHER).

Who is sponsoring clinical trial NCT04122001?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122001 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease, Early Onset

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04122001's enrollment target sits among peer trials

90 6th of 11 higher than 6 of 11 other Alzheimer Disease, Early Onset trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease, Early Onset trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04122001, the US trial registry maintained by the National Library of Medicine. NCT04122001 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.